Design, synthesis, and docking of highly hypolipidemic agents: Schizosaccharomyces pombe as a new model for evaluating alpha-asarone-based HMG-CoA reductase inhibitors.

Source:http://linkedlifedata.com/resource/pubmed/id/20576575

Bioorg. Med. Chem. 2010 Jun 15 18 12 4238-48

Download in:

View as

General Info

PMID
20576575